Acesso livre
Acesso livre

Reumatologia Pediátrica

Estudo de coorte | Associação entre doenças autoimunes maternas e risco de transtornos mentais nos descendentes na Dinamarca.

21 Abr, 2022 | 12:05h

Association of Maternal Autoimmune Diseases With Risk of Mental Disorders in Offspring in Denmark – JAMA Network Open

 

Comentário no Twitter

https://twitter.com/JAMANetworkOpen/status/1515057370715594753

 


Estudo randomizado | Eficácia e segurança de longo prazo de ixekizumabe por até 108 semanas em pacientes pediátricos com psoríase moderada a grave.

19 Abr, 2022 | 12:16h

Long-term Efficacy and Safety of Up to 108 Weeks of Ixekizumab in Pediatric Patients With Moderate to Severe Plaque Psoriasis: The IXORA-PEDS Randomized Clinical Trial – JAMA Dermatology

Estudo original: Efficacy and safety of ixekizumab in a phase III, randomized, double-blind, placebo-controlled study in paediatric patients with moderate-to-severe plaque psoriasis (IXORA-PEDS) – British Journal of Dermatology

 

Comentário no Twitter

 


Estudo de coorte | Preditores de doença grave em crianças com síndrome inflamatória multissistêmica após infecção pelo SARS-CoV-2.

14 Abr, 2022 | 16:58h

Predictors of severe illness in children with multisystem inflammatory syndrome after SARS-CoV-2 infection: a multicentre cohort study – Canadian Medical Association Journal

Comunicado de imprensa: Children older than 5 at higher risk of COVID-19-related multisystem inflammatory syndrome – Canadian Medical Association Journal

Comentário: Older Kids More Vulnerable to MIS-C: Study – HealthDay


Revisão de diretrizes nacionais | Fase aguda da doença de Kawasaki.

14 Abr, 2022 | 16:31h

Acute phase of Kawasaki disease: a review of national guideline recommendations – European Journal of Pediatrics


Revisão sistemática | Epidemiologia de manifestações musculoesqueléticas na doença inflamatória intestinal pediátrica.

8 Abr, 2022 | 21:21h

Epidemiology of Musculoskeletal Manifestations in Pediatric Inflammatory Bowel Disease: A Systematic Review – ACR Open Rheumatology


Diretriz BSR para tratamento de pacientes pediátricos, adolescentes e adultos com miopatia inflamatória idiopática.

5 Abr, 2022 | 12:04h

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy – Rheumatology


Metanálise de 56 estudos randomizados controlados | Intervenções farmacológicas para doença de Kawasaki em crianças.

1 Abr, 2022 | 12:59h

Pharmacologic interventions for Kawasaki disease in children: A network meta-analysis of 56 randomized controlled trials – eBioMedicine

Comentário: Network meta-analysis rates treatments for Kawasaki disease – medwire News


Diretriz | Tratamento da dor nas costas inespecífica em crianças e adolescentes.

29 Mar, 2022 | 14:57h

Treatment of Unspecific Back Pain in Children and Adolescents: Results of an Evidence-Based Interdisciplinary Guideline – Children


Diretriz da ACR/Vasculitis Foundation para o tratamento da doença de Kawasaki.

9 Mar, 2022 | 13:53h

2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Kawasaki Disease


Diretrizes ACR para o tratamento da artrite idiopática juvenil.

8 Mar, 2022 | 16:01h

Comunicado de imprensa: The American College of Rheumatology releases two updated guidelines for treatment of juvenile idiopathic arthritis – American College of Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Recommendations for Nonpharmacologic Therapies, Medication Monitoring, Immunizations, and Imaging – Arthritis & Rheumatology

2021 American College of Rheumatology Guideline for the Treatment of Juvenile Idiopathic Arthritis: Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis, and Systemic Juvenile Idiopathic Arthritis


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.